Sign In
Buy GEHC
$68.02
-1.92 (-2.75%)
At Close: Jul 31, 2026
DekaBank Deutsche Girozentrale Acquires 341 Shares of GE HealthCare Technologies Inc. $GEHC
04:12am, Sunday, 26'th Oct 2025
DekaBank Deutsche Girozentrale boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ: GEHC) by 0.6% during the second quarter, according to its most recent 13F filing with the Secu
GE Healthcare Technologies: A Solid Investment or a Missed Opportunity?
07:00pm, Thursday, 23'rd Oct 2025
Explore the exciting world of GE HealthCare Technologies (GEHC +1.47%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights
GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
02:25pm, Wednesday, 22'nd Oct 2025
GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced it has received CE mark for its Carevance™ patient monitor, advancing accessible and reliable care for more customers starting
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced collaborations with two leading U.S. health systems—The Queen's Health Systems in Honolulu, HI and Duke Health in Durham, NC—
GEHC Stock Up Following New Launch to Streamline Perinatal Workflow
03:01pm, Wednesday, 15'th Oct 2025
GE HealthCare unveils CareIntellect for Perinatal, a SaaS tool aimed at improving maternal and fetal care delivery.
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of CareIntellect™ for Perinatal2, a cloud-first Software-as-a-Service (SaaS) application designed to deliver clear,
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the presentation of findings from the largest real-world evidence study to-date on End-tidal Control anesthesia delivery* softwar
GE Healthcare Partners With Erasmus to Advance Precision Cancer Care
11:06am, Friday, 10'th Oct 2025
GEHC's collaboration with Erasmus MC aims to advance precision oncology using next-gen total body PET/CT and AI imaging innovations.
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the unveiling of Carestation™ 850, its next-generation, FDA 510(k) pendingi anesthesia delivery system that is designed to help
Market opportunities in the Automation in Medical Devices Manufacturing Market include leveraging automation to enhance precision and compliance, driven by
GE HealthCare to announce third quarter 2025 results on October 29, 2025
08:30am, Wednesday, 01'st Oct 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. The GE HealthCare management team
GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
10:26am, Friday, 26'th Sep 2025
GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.
GE HealthCare debuts AI-supported solution, designed to improve and shorten the radiation therapy workflow, at ASTRO 2025
09:00am, Thursday, 25'th Sep 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced updates to Intelligent Radiation Therapy (iRT), a new version of the company's software solution for radiation therapy workflow m
GE HealthCare announces cash dividend for third quarter of 2025
03:58pm, Wednesday, 24'th Sep 2025
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the third quarter of 2025 paya
